Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Neutral
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Buy
Wall Street Data Solutions Rating
Neutral
B
Silence Therapeutics Plc American Depository Share (SLN)
https://www.silence-therapeutics.com
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risk of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
09/08/2020
Market Cap
743,818,464
Shares Outstanding
107,810,000
Weighted SO
38,669,929
Total Employees
N/A
Upcoming Earnings
N/A
Beta
1.2970
Last Div
0.0000
Range
6.15-27.72
Chg
-0.8000
Avg Vol
204112
Mkt Cap
743818464
Exch
NASDAQ
Country
GB
Phone
44 20 3457 6900
DCF Diff
17.2633
DCF
5.5767
Div Yield
0.0000
P/S
21.7664
EV Multiple
-11.6471
P/FV
4.3785
Div Yield %
0.0000
P/E
-15.5273
PEG
-2.1738
Payout
0.0000
Current Ratio
12.8198
Quick Ratio
12.8198
Cash Ratio
7.9752
DSO
260.2700
DIO
0.0000
Op Cycle
260.2700
DPO
478.6489
CCC
-218.3789
Gross Margin
0.6972
Op Margin
-1.5758
Pretax Margin
-1.5527
Net Margin
-1.3231
Eff Tax Rate
0.1479
ROA
-0.1797
ROE
-0.8069
ROCE
-0.2309
NI/EBT
0.8521
EBT/EBIT
0.9854
EBIT/Rev
-1.5758
Debt Ratio
0.0014
D/E
0.0022
LT Debt/Cap
0.0008
Total Debt/Cap
0.0022
Int Coverage
-48.8966
CF/Debt
-141.4765
Equity Multi
1.5688
Rec Turnover
1.4024
Pay Turnover
0.7626
Inv Turnover
0.0000
FA Turnover
14.7443
Asset Turnover
0.1359
OCF/Share
-0.8915
FCF/Share
-0.8919
Cash/Share
3.4748
OCF/Sales
-1.4840
FCF/OCF
1.0005
CF Coverage
-141.4765
ST Coverage
-212.9837
CapEx Coverage
-2177.1667
Div&CapEx Cov
-2177.1667
P/BV
4.3785
P/B
4.3785
P/S
21.7664
P/E
-15.5273
P/FCF
-14.6603
P/OCF
-13.8433
P/CF
-13.8433
PEG
-2.1738
P/S
21.7664
EV Multiple
-11.6471
P/FV
4.3785
DPS
0.0000